SCHEMBL11048786

SCHEMBL11048786

O=C(NCC(O)C1COc2ccccc2O1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.61
RAB9A P51151 4/20 0.61
NPC1 O15118 3/20 0.61
HPGD P15428 2/20 0.61
CYP2C19 P33261 1/20 0.51
ALDH1A1 P00352 4/20 0.51
GLA P06280 1/20 0.51
ALOX12 P18054 1/20 0.51
MAPT P10636 3/20 0.50
TSHR P16473 1/20 0.50
LMNA P02545 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
KMT2A Q03164 4/20 0.49
MEN1 O00255 2/20 0.47
KDM4E B2RXH2 2/20 0.46
GAA P10253 2/20 0.46
POLB P06746 1/20 0.46
HTT P42858 1/20 0.45
MTNR1A P48039 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bendacalol SCHEMBL11047717 0.81 LMNA (0.52) SMN1; SMN2HPGDALDH1A1MAPTLMNA
Bendacalol SCHEMBL11050612 0.79 LMNA (0.51) SMN1; SMN2HPGDALDH1A1MAPTLMNA
SCHEMBL7441442 0.78 LMNA (0.50) SMN1; SMN2ALDH1A1MAPTLMNANPSR1
SCHEMBL11046528 0.77 SMN1; SMN2 (0.47) SMN1; SMN2RAB9ANPC1HPGDCYP2C19
Bendacalol SCHEMBL29400550 0.76 LMNA (0.52) SMN1; SMN2HPGDALDH1A1MAPTLMNA
Bendacalol SCHEMBL588993 0.76 LMNA (0.52) SMN1; SMN2HPGDALDH1A1MAPTLMNA
SCHEMBL7435319 0.76 EPHX1 (0.47) SMN1; SMN2RAB9ANPC1HPGDCYP2C19
SCHEMBL11469283 0.76 MAPT (0.52) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL16492844 0.76 ADRB2 (0.46) SMN1; SMN2RAB9AHPGDALDH1A1MAPT
Hydrochloric Acid SCHEMBL11044563 0.75 POLB (0.50) SMN1; SMN2HPGDALDH1A1ALOX12MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4471127-A 1-5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols CIBA-GEIGY CORPORATION (US) 1984-09-11 US claimed
EP-0050585-B1 1,5-BIS-(1,4-BENZODIOXIN-2-YL)-3-AZAPENTANE-1,5 DIOLS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR THERAPEUTICAL USE CIBA-GEIGY AG (CH) 1984-10-03 EP disclosed
US-4471127-A 1-5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols CIBA-GEIGY CORPORATION (US) 1984-09-11 US disclosed
US-4471128-A 1,5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols CIBA-GEIGY CORPORATION (US) 1984-09-11 US disclosed
US-4380653-A HYPOTENSIVES, CARDIOVASCULAR DISORDERS CIBA-GEIGY CORPORATION (US) 1983-04-19 US disclosed